Like this podcast? Create your own with Apisod

FSSAI Targets Horlicks Health Claims

Show Notes
India’s food safety watchdog just put Hindustan Unilever on notice, challenging claims like “Healthy Birth Weight” on a Horlicks nutrition product and warning that legal action and ad takedowns could follow. It’s not just one product—regulators are signaling a crackdown across the entire nutrition and personal care sector, forcing brands to police every claim on pack and online. With inflation biting and festive season demand heating up, HUL faces the risk of costly compliance fixes and potential shelf disruptions, all while rivals like ITC and Colgate eye a chance to grab share.
But here’s the catch: even as HUL juggles regulatory risk, analysts are flagging a profit squeeze. Revenue might rise, but margins are forecast to shrink by 150 basis points this year as raw material prices outpace selective price hikes. Add in the pressure of major portfolio moves—Unilever’s ice cream spin-out, the Foods merger with McCormick, and aggressive share buybacks—and investors are left asking: can volume growth keep up, or are premium brands and sustainability bets just window dressing if the core business stumbles?
Based on reporting and analysis from Finimize, Kalkine Media, and insights from Unilever’s R&D chief and industry analysts.
Powered by Apisod.com